Jeonjinbio Statistics

Total Valuation

Jeonjinbio has a market cap or net worth of KRW 21.56 billion. The enterprise value is 14.90 billion.

Market Cap	21.56B
Enterprise Value	14.90B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 18.14% in one year.

Current Share Class	n/a
Shares Outstanding	9.06M
Shares Change (YoY)	+18.14%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	3.99%
Float	7.94M

Valuation Ratios

The trailing PE ratio is 4.71.

PE Ratio	4.71
Forward PE	n/a
PS Ratio	1.06
PB Ratio	1.22
P/TBV Ratio	1.22
P/FCF Ratio	8.24
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.96, with an EV/FCF ratio of 5.70.

EV / Earnings	3.43
EV / Sales	0.77
EV / EBITDA	5.96
EV / EBIT	12.87
EV / FCF	5.70

Financial Position

The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.01.

Current Ratio	9.34
Quick Ratio	8.47
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	0.04
Interest Coverage	2.68

Financial Efficiency

Return on equity (ROE) is 36.40% and return on invested capital (ROIC) is 4.90%.

Return on Equity (ROE)	36.40%
Return on Assets (ROA)	3.96%
Return on Invested Capital (ROIC)	4.90%
Return on Capital Employed (ROCE)	6.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.05
Inventory Turnover	9.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.10% in the last 52 weeks. The beta is -0.47, so Jeonjinbio's price volatility has been lower than the market average.

Beta (5Y)	-0.47
52-Week Price Change	-68.10%
50-Day Moving Average	2,672.20
200-Day Moving Average	2,891.60
Relative Strength Index (RSI)	32.68
Average Volume (20 Days)	32,323

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jeonjinbio had revenue of KRW 19.27 billion and earned 4.35 billion in profits. Earnings per share was 505.00.

Revenue	19.27B
Gross Profit	6.00B
Operating Income	1.16B
Pretax Income	4.35B
Net Income	4.35B
EBITDA	2.50B
EBIT	1.16B
Earnings Per Share (EPS)	505.00

Full Income Statement

Balance Sheet

The company has 6.75 billion in cash and 92.62 million in debt, giving a net cash position of 6.66 billion or 734.74 per share.

Cash & Cash Equivalents	6.75B
Total Debt	92.62M
Net Cash	6.66B
Net Cash Per Share	734.74
Equity (Book Value)	17.66B
Book Value Per Share	1,944.89
Working Capital	9.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.01 billion and capital expenditures -389.47 million, giving a free cash flow of 2.62 billion.

Operating Cash Flow	3.01B
Capital Expenditures	-389.47M
Free Cash Flow	2.62B
FCF Per Share	288.75

Full Cash Flow Statement

Margins

Gross margin is 31.14%, with operating and profit margins of 6.01% and 22.55%.

Gross Margin	31.14%
Operating Margin	6.01%
Pretax Margin	22.55%
Profit Margin	22.55%
EBITDA Margin	12.97%
EBIT Margin	6.01%
FCF Margin	13.57%

Dividends & Yields

Jeonjinbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.14%
Shareholder Yield	-18.14%
Earnings Yield	20.16%
FCF Yield	12.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jeonjinbio has an Altman Z-Score of 20.27.

Altman Z-Score	20.27
Piotroski F-Score	n/a